Pricing Log in Create free account

Insmed, Inc. (INSM) vs BeOne Medicines Ltd. - Sponsored ADR (ONC)

Insmed, Inc. and BeOne Medicines Ltd. - Sponsored ADR are both Biotechnology companies. BeOne Medicines Ltd. - Sponsored ADR is the larger, with a market value of $40.4B against $23.9B — 1.7× the size. Insmed, Inc. has negative trailing earnings, so its P/E is not meaningful; BeOne Medicines Ltd. - Sponsored ADR trades at 65.9×. Insmed, Inc. grew revenue faster over the last twelve months: 240.0% against 32.9%. BeOne Medicines Ltd. - Sponsored ADR has the higher net margin (13.9% vs −39.9%) and the higher return on invested capital (85.2% vs −247.6%). Across the 18 metrics below, BeOne Medicines Ltd. - Sponsored ADR leads on 17 and Insmed, Inc. on 1.

Valuation

Metric INSM ONC Biotechnology median
P/E n/m 65.91 10.26
P/S 15.60 6.57 9.18
P/B 32.64 7.45 2.05
Price to free cash flow n/m 30.36 24.81
EV/EBITDA n/m 28.56 0.65
EV/Sales 15.36 5.87 8.98
Earnings yield (2.60%) 1.52% (34.89%)
Free cash flow yield (2.65%) 3.29% (24.52%)

Profitability

Metric INSM ONC Biotechnology median
Gross margin 84.40% 89.39% 65.16%
Operating margin (37.11%) 17.84% 0.00%
Net margin (39.85%) 13.86% 0.00%
Free cash flow margin (41.30%) 21.94% 0.00%
Return on equity (72.45%) 18.40% (50.12%)
Return on assets (26.41%) 10.46% (45.60%)
Return on invested capital (247.55%) 85.21% 0.00%

Growth

Metric INSM ONC Biotechnology median
Revenue growth (TTM) 239.97% 32.86% 6.26%
EPS growth (last fiscal year) (15.26%) 141.34% 29.88%
Revenue growth, 5-year CAGR 29.83% 76.85% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric INSM ONC Biotechnology median
Debt to equity 0.78 0.14 0.00
Current ratio 2.86 3.55 4.89
Net debt to EBITDA 0.71 (6.09) 1.01

Dividend

Metric INSM ONC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric INSM ONC Biotechnology median
Market cap 23.86b 40.38b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack